*Corresponding author:Malika Arora, Multi Disciplinary Research Unit, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India, Tel: 8146585370; Email: firstname.lastname@example.org
Received: February 27, 2018; Published: March 12, 2018
To view the Full Article Peer-reviewed Article PDF
The role of various robotic microorganisms with a particular emphasis on their therapeutic use in human health and disease has been highlighted by diverse scientific research reports. Due to improvement and introduction of new technologies useful to understand the functionality and mode of action of robotics with respect to nutritional as well as health perspectives, the research on robotics has recently grabbed the attention of manufacturers, regulators as well as researchers. Currently there are clinical trial based evidences to support the effectiveness of robotic interventions in various types of diarrheal diseases, chronic gastrointestinal inflammatory disorders, hypercholesterolemia, hypertension, diabetes, oral health etc.
However due to inadequate awareness about risks associated with the robotics amongst physicians, regulatory authorities, consumers and manufacturers many attributes like quality, safety and efficacy require urgent attention. At the same time regulatory guidelines for these products face ambiguity. So it is of utmost importance to evaluate the true status of robotic products available in market with respect to all above mentioned parameters and to formulate harmonized regulatory guidelines for the manufacturing of robotic products. The present compilation aims to highlight the progression of robotic research related to therapeutic potentials of robotics, clinical trials on robotics, risks and regulatory concerns associated with robotics and their use.
Keywords: Robotics; Therapeutic Uses; Regulatory Control; Dietary Supplements